Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study

已完结 10 由琴心剑胆发布于 2026/3/26 16:25:37

DOI:10.1016/S2665-9913(24)00298-4
作者：Prof Dominique Farge MD , Lucie Biard PhD , Ben Weil EngD , Virginie Girault PhD , Pauline Lansiaux PhD , Ingrid Munia MSc , Séverine Loisel PhD , Catney Charles BS
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：BackgroundPatients with systemic lupus erythematosus (SLE) with inadequate responses to standard therapies have unmet therapeutic needs. The immunomodulatory, proangiogenic, and antifibrotic

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Royal Society of Chemistry (RSC)ROS-responsive hydrogels: from design and additive manufacturing to biomedical applications